Registered entities
MOLECULIGHT CORP.
Reg. No. 32073694641United States
Innovation
15 patent families (11 granted) — focus: Human necessities, Physics & computing, Electricity & electronics; filing pace steady. Cited 1,458 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 5 |
Social engagement
Social engagement: 6.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Export Development Canada, Prosegur.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 22% |
| Accelerator & incubator | 1 | 11% |
| Bank & private debt | 2 | 22% |
| Other / undisclosed | 4 | 44% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
29 Apr 2026 · Director of Medical Communications · Toronto
7 Sep 2025 · Clinical Trial Associate · Toronto
24 Apr 2025 · Electrical Technician · Toronto
24 Apr 2025 · Medical Communications Manager · Toronto
Based on job postings tracked across public sources.
Recent activity
16 Jun 2026
Product launch
MolecuLightDX+
12 Jun 2026
Event
Annual St. Louis Wound & Vascular Symposium (SLWVS)
28 May 2026
Event
Annual St. Louis Wound & Vascular Symposium (SLWVS)